fexaramine

structure in first source

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

1.	Bone Resorption 11/01/2017 - "Furthermore, fexaramine diminished the RANKL-stimulated bone resorption. " 11/01/2017 - "Thus, fexaramine could be useful for the treatment of bone diseases associated with excessive bone resorption."
2.	Bone Diseases (Bone Disease) 11/01/2017 - "Thus, fexaramine could be useful for the treatment of bone diseases associated with excessive bone resorption."
3.	Liver Diseases (Liver Disease) 02/01/2024 - "Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease."
4.	Endometritis 05/01/2023 - "The results showed that LPS administration reduced the expression of FXR in the uterus, and treatment with the FXR agonist GW4064 and fexaramine significantly alleviated the endometritis induced by LPS. "

1.	GW 4064